• Qui Tam
  • SEC
  • CFTC
  • FCPA
  • Whistleblower Resources
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
The Truth at Any Cost.
Qui Tam, Compliance and Anti-Corruption News.
SIGN THE PETITION FOR NATIONAL WHISTLEBLOWER DAY IN 2023
Whistleblower Network News
  • Qui Tam
  • SEC
  • CFTC
  • FCPA
  • Whistleblower Resources
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
No Result
View All Result
Home Corporate

Whistleblowers call out pharma sales tactics that can add up to Medicare fraud

Tinker ReadybyTinker Ready
May 2, 2019
in Corporate, News
Reading Time: 3 mins read
Share on TwitterShare on FacebookShare on LinkedInEmail

Two whistleblower cases unsealed this week reveal how aggressive pharmaceutical marketing programs can cross the line into Medicare fraud and kickbacks. Trips to the Kentucky Derby for doctors and huge bonuses for sales reps can lead to bribes, conflicts of interest and poor-quality care.

Illustration: Tinker ReadyIn one case, a drug maker was competing with a far less expensive, easier-to-administer alternative. Sales reps reportedly told doctors they could shorten a two-to-three week treatment with the Questcor’s expensive anti-seizure drug to one week. However, the Food and Drug Administration had not vetterd the efficacy of the one-week course, according to the case.

US WorldMeds

In the settlement case, the company is charged with secretly covering co-pays for all Medicare patients –not just those in need — thus insulating them from a steep price hike. Good for the patients, whose co-pays could have reached $5,000, DOJ noted; bad for the rest of us, who have to pay the balance. That’s why the approach is considered a kickback.

Support Whistleblower Network News

The Department of Justice (DOJ) announced Tuesday that US WorldMeds will pay $17.5 million under the False Claims act to resolve kickback allegations related to two drugs. The company is based in Louisville. One of the kickbacks the DOJ cited was a trip to the Kentucky Derby for two doctors. The whistleblowers who brought the original qui tam case will be paid $3.2 million

Questcor

The Questcor case was also initiated by whistleblowers. It is described in an unsealed seven-year-old complaint first detailed by CNN Tuesday. The company, now owned by Irish drug-maker Mallinckrodt, used generous bonuses, aggressive sales tactics and fraud to sell the expensive anti-seizure treatment, the complaint charges.

In a statement, Mallinckrodt “strongly disagrees with the substance of the complaints and the sensational characterization of the allegations.” It notes that the company has been working with the DOJ on a settlement.

Two company sales representatives filed the cases in 2012. One of them alleges the company fired her when she tried to raise the issues.

Questcor first made headlines in 2000 when it raised the price of the $50 anti-seizure drug to more than $20,000 –it is now up to $39,000 for a vial, according to CNN. A 2012 story in The New York Times reported the story behind the price hike is “a tale of aggressive marketing, questionable medicine and, not least, out-of-control costs.”

The whistleblowers’ complaints turn on the same sales tactics described in the Times story.The company’s strategy was to promote of “off-label” uses, which have not been vetted by the Food and Drug Administration (FDA). Doctors are allowed to use drugs off-label, but drug makers are prohibited from promoting uses not approved by the FDA. According to the suit:

Defendant expressly tied sales specialist compensation to sales growth, and it incentivized each sales specialist to increase sales growth irrespective of the rules against off-label marketing. Indeed, the company’s bonus structure ·which paid hefty bonuses each month based on the number of prescriptions shipped· was designed to promote a “sell at all cost” mentality within the sales force.

Resources

  • NWC: What is the False Claims Act?
  • NWC: SEC whistleblower protection 
  • Fierce Pharma: More trouble for Mallinckrodt: DOJ joins the fray in Acthar whistleblower suits
Tags: Medicare fraudPharmaceuticals
Previous Post

For Federal Bureau of Investigation whistleblowers, recommended changes come slowly

Next Post

Former White House boss denies claims of security clearance whistleblower

Tinker Ready

Tinker Ready

In 2019, Tinker Ready was the editor-in-chief of the Whistleblower Protection Blog.  She has worked with whistleblowers throughout her career as a journalist and investigative reporter.  

Next Post
Former White House boss denies claims of security clearance whistleblower

Former White House boss denies claims of security clearance whistleblower

Please login to join discussion

Receive Daily Alerts

Subscribe to receive daily breaking news and legislative developments sent to your inbox.

  • This field is for validation purposes and should be left unchanged.

Most Popular

US Attorneys Reflect on UK’s Whistleblowing Awareness Week

OSHA Highlights Railroad Worker Whistleblower Protections in Wake of Train Derailments

AML Whistleblower Law Could Shift the Way DOJ Handles Whistleblowers

Two Powerful Women Whistleblower Pairs to Learn From This Women’s History Month

WNN Exclusive Interview with Social Security Whistleblowers Sarah Carver and Jennifer Griffith — Part 2

Change the Culture, Make National Whistleblower Day Permanent

Whistleblower Poll

Whistleblower Poll
Whistleblower Poll

Exclusive Marist Poll: Overwhelming Public Support Among Likely Voters For Increased Whistleblower Protections

byGeoff Schweller
October 6, 2020

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

STAY INFORMED.
Subscribe to receive breaking whistleblower updates.

  • This field is for validation purposes and should be left unchanged.

About Us

  • About
  • Contact Us
  • Donate
  • Careers

Subscribe

  • Daily Mail
  • Follow us on Twitter
  • YouTube Channel

Contribute

  • Letter to the Editor
  • Submission Guidelines
  • Reprint Guidelines

Your Experience

  • Accessibility Statement
  • Privacy Policy
  • Terms of Use

Help

  • The Whistleblowers Handbook
  • Frequently Asked Questions
  • Advertise
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article

Copyright © 2021, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

SIGN THE PETITION FOR NATIONAL WHISTLEBLOWER DAY IN 2023
No Result
View All Result
  • Exclusives
  • Government
    • False Claims-Qui Tam
    • Federal Employees
    • Intelligence
  • Corporate
    • CFTC & Commodities
    • Dodd-Frank
    • IRS & Tax
    • SEC & Securities
  • Features
  • Legislation
  • International
    • Foreign Corruption
  • Rewards
  • Whistleblower of the Week
  • Environment & Climate
  • Opinion
  • Editorial
  • Employment
    • Sarbanes-Oxley Whistleblowers
    • Retaliation
    • OSHA
  • Media
    • Podcasts
    • Videos
    • Webinars
    • National Whistleblower Day
  • Whistleblower Poll
  • Whistleblower Resources
    • Frequently Asked Questions
    • Resources for Locating An Attorney
    • The New Whistleblowers Handbook
  • National Whistleblower Day ’23

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

Become a Whistleblower Network News Subscriber

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Subscribe to WNN

Retrieve your password

Please enter your username or email address to reset your password.

Subscribe to WNN

Add New Playlist

Go to mobile version